SLK Kliniken Heilbronn GmbH

Heilbronn, Germany

We are proud to announce that SLK Kliniken Heilbronn in Germany has been recognized as an IASIOS Centre of Excellence, becoming the third centre worldwide and the very first in Germany to achieve this distinction.

The Centre of Excellence designation is the highest level of recognition within IASIOS, confirming that SLK Kliniken Heilbronn fulfils both the core and extended criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. This recognition means that the entire interventional oncology patient pathway at the centre follows a systematic and structured approach, where every patient receives consistent and high-quality care. Staff competence, advanced facility infrastructure, precise treatment delivery, and rigorous standards of radiation safety are all upheld at the highest international level.

We commend the dedication and commitment of Prof. Pereira, Prof. Grözinger, Dr. Speck, Dr. Mayer, Mr. Hermann, Dr. Wandschneider and the entire interventional radiology team at SLK Kliniken Heilbronn. Their achievement represents an outstanding contribution to clinical quality in interventional oncology and serves as an inspiration to the global IO community.

Dr. Sina Speck

IASIOS Council Member

(SLK-Kliniken Heilbronn, Germany)

Amsterdam UMC

Nijmegen, Netherlands

We are proud to share that Amsterdam UMC in the Netherlands has been recognised as an IASIOS Accredited Centre. This achievement confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

Under the leadership of Prof. Martijn Meijerink, the team has shown a clear dedication to safety, quality, and patient-centred care in interventional oncology.

Prof. Martijn Meijerink

IASIOS Council Member

(Amsterdam University Medical Centre, Netherlands)

Charité Universitätsmedizin Berlin

Berlin, Germany

Congratulations to Charité Universitätsmedizin Berlin in Germany on becoming an IASIOS Accredited Centre. This achievement affirms that their interventional oncology service adheres to the international standards of quality and safety. Under the leadership of Prof. Dr. Bernhard Gebauer, the team has demonstrated a strong commitment to structured, patient-centered care and continuous quality improvement. We value their dedication to this milestone and look forward to their continued success within the IASIOS community.

Hunter New England Medical Imaging

New Lambton Heights, Australia

John Hunter Hospital, part of the Hunter New England Medical Imaging network

We are delighted to share that Hunter New England Medical Imaging in New Lambton Heights, Australia, has joined IASIOS as an Enrolled Centre. Under the leadership of Dr. Christian Abel, the team is taking an important step towards strengthening quality in interventional oncology.

We look forward to supporting them on their accreditation journey.

National Institutes of Health

Bethesda, Maryland

We are pleased to announce that the National Institutes of Health (NIH) in Bethesda, Maryland, has become an IASIOS Accredited Centre.This recognition confirms that its interventional oncology service line meets all core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology.

Led by Dr Brad Wood, the accreditation reflects the team’s outstanding commitment to quality, safety, and standardisation in patient care.
As a leader in medical research and healthcare, NIH sets an important example by aligning world-class expertise with internationally standardised pathways in interventional oncology.

We extend our warmest congratulations to Dr Wood and the entire team for this outstanding achievement.

Städtisches Klinikum Karlsruhe

Karlsruhe, Germany

We are pleased to announce that Staedtisches Klinikum Karlsruhe in Germany is now recognised as an IASIOS Accredited Centre. This confirms that its interventional oncology service meets the core criteria of the CIRSE Standards of Quality Assurance in Interventional Oncology. Under the leadership of Prof. Peter Reimer, the team has shown a clear commitment to structured, patient-centred care and continuous quality improvement. We value their dedication and warmly congratulate them on this achievement.

Centre Hospitalier de l’Université de Montréal

Montreal, Canada

We are pleased to welcome Centre Hospitalier de l’Université de Montréal as the first Canadian facility to join IASIOS as an Enrolled Centre. Their enrolment highlights a growing commitment in Canada to strengthening quality assurance in cancer care and advancing interventional oncology through a structured globally recognized framework. We value the team’s dedication to this important step and will provide support as they move towards accreditation.

AOUI Verona, Polo Confortini Ospedale Civile Maggiore Borgo Trento

Verona, Italy

We are pleased to welcome another facility from Italy, Azienda Ospedaliera Universitari Integrata di Verona, Polo Confortini Ospedale Civile Maggiore Borgo Trento, as an IASIOS Enrolled Centre. This enrolment marks the beginning of their journey towards aligning the interventional oncology patient pathway with international quality assurance standards, and we commend the team for their dedication.

MIOT HOSPITALS Private Limited

Chennai, India

A major milestone for our global community — MIOT Hospitals Private Limited in Chennai has become the first facility in India to be recognised as an IASIOS Accredited Centre.

This achievement confirms that the hospital’s interventional oncology service line meets the core criteria of the CIRSE Standards of Quality Assurance, supported by over 40 national and international societies.

We congratulate the entire team at MIOT Hospitals for their commitment to delivering high-quality, structured care in interventional oncology and for setting a benchmark for excellence in the region.

Mount Elizabeth Hospital (Orchard), Mount Elizabeth Novena Hospital, Gleneagles Hospital

Singapore

We are pleased to announce the enrolment of three hospitals from the Parkway Hospitals network: Mount Elizabeth Hospital (Orchard), Mount Elizabeth Novena Hospital, and Gleneagles Hospital — all located in Singapore.

This marks another important step for interventional oncology in the region, with Singapore continuing to lead the way in advancing high standards of care.

We congratulate the interventional radiology teams at all three hospitals for their commitment to quality, structure, and continuous improvement through the IASIOS accreditation pathway.